Table 3.
Experiment 2: Animal attrition and incidence and timing of autophagia
| Rat | Group | Day of onset | Site | Relative to vectora | Severity |
|---|---|---|---|---|---|
| 27 | shPTEN-Fibrin | 4 | Forepaw | Contralateral | Mild |
| 31 | Untreated | 4 | Forepaw | Contralateral | Severe |
| 33 | shPTEN-Fibrin | 7 | Forepaws | Both | Moderate |
| 18 | shPTEN-Fibrin | 11 | Forepaw | Contralateral | Severe |
| 8 | shPTEN/shSOCS3-Fibrin | 13 | Forepaw | Contralateral | Mild |
| 37 | shPTEN/shSOCS3-Fibrin | 13 | Forepaw | Contralateral | Moderate |
| 8 | shPTEN/shSOCS3-Fibrin | 14 | Forepaw | Ipsilateral | Mild |
| 14 | shPTEN-Fibrin | 14 | Forepaw | Ipsilateral | Mild |
| 19 | shPTEN-Fibrin | 14 | Forepaw | Contralateral | Mild |
| 5 | Untreated | 15 | Forepaw | Contralateral | Mild |
| 2 | shPTEN/shSOCS3-Fibrin | 19 | Hindpaw | Contralateral | Mild |
| 25 | Untreated | 22 | Forepaw | Ipsilateral | Mild |
| 9 | shPTEN/shSOCS3-Fibrin | 24 | Forepaw | Contralateral | Mild |
| 24 | shPTEN-Fibrin | 24 | Hindpaw | Contralateral | Moderate |
| 26 | shPTEN/shSOCS3-Fibrin | 24 | Forepaw | Contralateral | Moderate |
| 40 | Untreated | 28 | Hindpaw | Contralateral | Severe |
| 10 | Untreated | 29 | Hindpaw | Ipsilateral | Mild |
| 41 | shPTEN/shSOCS3-Fibrin | 30 | Forepaw | Contralateral | Mild |
| 46 | shPTEN/shSOCS3-Fibrin | 30 | Hindpaw | Ipsilateral | Mild |
| 18 | shPTEN-Fibrin | 31 | Hindpaw | Ipsilateral | Moderate |
| 21 | Untreated | 34 | Forepaw | Ipsilateral | Mild |
| 12 | shPTEN-Fibrin | 35 | Hindpaw | Contralateral | Mild |
| 30 | Untreated | 39 | Forepaw | Contralateral | Moderate |
| 4 | shPTEN-Fibrin | 46 | Hindpaw | Contralateral | Mild |
| 34 | shPTEN-Fibrin | 48 | Forepaw | Contralateral | Mild |
| 44 | shPTEN/shSOCS3-Fibrin | 54 | Forepaw | Ipsilateral | Mild |
| 31 | Untreated | 62 | Hindpaw | Contralateral | Moderate |
| 30 | Untreated | 65 | Forepaw | Ipsilateral | Moderate |
| 48 | Untreated | 66 | Hindpaw | Ipsilateral | Moderate |
| 41 | shPTEN/shSOCS3-Fibrin | 72 | Hindpaw | Ipsilateral | Mild |
| 42 | shPTEN-Fibrin | 72 | Hindpaw | Ipsilateral | Mild |
| 45 | shPTEN/shSOCS3-Fibrin | 72 | Hindpaw | Ipsilateral | Mild |
| 46 | shPTEN/shSOCS3-Fibrin | 83 | Forepaw | Ipsilateral | Mild |
aLaterality in terms of AAV injection.